Core Viewpoint - As of December 26, 2025, Maide Medical (688310) closed at 15.47 yuan, down 1.59%, with a turnover rate of 1.46% and a trading volume of 24,300 lots, amounting to 38.0012 million yuan in transaction value [1] Group 1: Financial Performance - For the first three quarters of 2025, Maide Medical reported a main revenue of 225 million yuan, an increase of 2.31% year-on-year [2] - The net profit attributable to shareholders was 8.8367 million yuan, up 15.82% year-on-year [2] - The non-recurring net profit was -1.2785 million yuan, a significant decrease of 526.58% year-on-year [2] - In Q3 2025, the company achieved a single-quarter main revenue of 83.643 million yuan, a year-on-year increase of 54.38% [2] - The single-quarter net profit attributable to shareholders was 2.7916 million yuan, up 224.07% year-on-year [2] - The single-quarter non-recurring net profit was 1.2364 million yuan, an increase of 118.23% year-on-year [2] - The company's debt ratio stood at 29.86%, with investment income of 167,600 yuan and financial expenses of -523,600 yuan, while the gross profit margin was 40.19% [2] Group 2: Business Overview - Maide Medical specializes in the research, production, sales, and service of medical consumables and intelligent equipment, effectively integrating technology in medical device processes, automation, and software [2]
股票行情快报:迈得医疗(688310)12月26日主力资金净买入315.12万元